Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment-Reference-Cited by-同舟云学术

Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment

Published:2014-11-11 Issue:6 Volume:171 Page:1434-1442
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Kimball A.B.¹,Jemec G.B.E.²,Yang M.³,Kageleiry A.³,Signorovitch J.E.³,Okun M.M.⁴,Gu Y.⁴,Wang K.⁵,Mulani P.⁴,Sundaram M.⁴

Affiliation:

1. Department of Dermatology; Harvard Medical School; Boston MA U.S.A

2. Department of Dermatology; Roskilde Hospital; Health Sciences Faculty; University of Copenhagen; Copenhagen Denmark

3. Analysis Group, Inc.; Boston MA U.S.A

4. Global Pharmaceutical Research and Development; AbbVie Inc.; North Chicago IL U.S.A

5. Lilly Suzhou Pharmaceutical Co. Ltd, Shanghai Branch; Shanghai China

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjd.13270/fullpdf

Reference21 articles.

1. Hidradenitis suppurativa;Revuz;J Eur Acad Dermatol Venereol,2009

2. Epidemiology

3. Painful hidradenitis suppurativa;Smith;Clin J Pain,2010

4. A systematic review of treatments for hidradenitis suppurativa;Rambhatla;Arch Dermatol,2012

5. Adalimumab for the treatment of moderate to severe hidradenitis suppurativa: a parallel randomized trial;Kimball;Ann Intern Med,2012

Cited by 180 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the Role of Adalimumab in Treating Hidradenitis Suppurativa: Findings from a Retrospective Study at a Reference Center;Clinics and Practice;2024-08-27

2. Placebo responders with moderate-to-severe hidradenitis suppurativa experience declines in inflammation as measured by C-reactive protein: a post hoc analysis of two double-blinded, randomized-controlled trials;International Journal of Women’s Dermatology;2024-08-21

3. The role of piperacillin/tazobactam in the treatment of Hidradenitis suppurativa;Journal of Dermatological Treatment;2024-08-05

4. Tratamiento quirúrgico en la hidradenitis supurativa: análisis de una serie de casos;Piel;2024-08

5. Guidelines How to Integrate Surgery and Targeted Therapy with Biologics for the Treatment of Hidradenitis Suppurativa: Delphi Consensus Statements from an Italian Expert Panel;Dermatology;2024-07-18